4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001577014-26-000014
Director sold 777,451 shares at an average $22.97 ($17,858,492)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rhodes Jason P Director | 2026-07-06 | Sale 10b5-1 | −253,039 | $22.79 | $5,766,759 | 4,223,448 | I |
| Rhodes Jason P Director | 2026-07-06 | Sale 10b5-1 | −127,182 | $22.79 | $2,898,478 | 1,217,537 | I |
| Rhodes Jason P Director | 2026-07-06 | Sale 10b5-1 | −100,019 | $22.79 | $2,279,433 | 875,912 | I |
| Rhodes Jason P Director | 2026-07-07 | Sale 10b5-1 | −124,379 | $23.17 | $2,881,861 | 4,099,069 | I |
| Rhodes Jason P Director | 2026-07-07 | Sale 10b5-1 | −29,587 | $23.62 | $698,845 | 4,069,482 | I |
| Rhodes Jason P Director | 2026-07-07 | Sale 10b5-1 | −62,543 | $23.17 | $1,449,121 | 1,154,994 | I |
| Rhodes Jason P Director | 2026-07-07 | Sale 10b5-1 | −14,844 | $23.62 | $350,615 | 1,140,150 | I |
| Rhodes Jason P Director | 2026-07-07 | Sale 10b5-1 | −49,193 | $23.17 | $1,139,802 | 826,719 | I |
| Rhodes Jason P Director | 2026-07-07 | Sale 10b5-1 | −11,665 | $23.62 | $275,527 | 815,054 | I |
| Rhodes Jason P Director | 2026-07-07 | Sale 10b5-1 | −5,000 | $23.61 | $118,050 | 2,962 | I |
| Open-market sales · 777,451 sh · avg $22.97 · $17,858,492 | |||||||
Loading xslF345X06/form4-07082026_090708.xml…